Why Amarin Fell Again Today

Why Amarin Fell Again Today

This surely won't be a week to remember for Amarin (NASDAQ: AMRN). Following Monday's stinging Supreme Court loss regarding patent protection for its one and only commercialized drug, on Tuesday one of the company's rivals announced the launch of a new generic for that product. Amarin's shares fell by 3.2%.